3 Chemical Structures and Biological Activities of Non-Peptide Selective Kappa Opioid Ligands
Author:
- 1 January 1992
- book chapter
- Published by Elsevier in Progress in Medicinal Chemistry
- Vol. 29, 109-139
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonistsJournal of Medicinal Chemistry, 1991
- PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in ratsLife Sciences, 1990
- Synthesis of (1′, 2′-trans)-3-phenyl-1-[2′-(N-pyrrolidinyl)cyclohexyl]-pyrrolid-2-ones as κ-selective opiatesJournal of Pharmaceutical Sciences, 1990
- Conformational characteristics of opioid .KAPPA.-receptor agonist: Crystal structure of (5S, 7S, 8S)-(-)-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)benzeneacetamide (U69,593), and conformational comparison with some .KAPPA.-agonists.Chemical and Pharmaceutical Bulletin, 1990
- Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: Tentative mu-2 opioid control of mesocortical dopaminergic projectionsLife Sciences, 1987
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Kappa receptor mediated opioid dependence in rhesus monkeysLife Sciences, 1986
- Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agentLife Sciences, 1985
- Compounds of novel structure having kappa-agonist behavioral effects in Rhesus monkeysLife Sciences, 1982
- Properties of a selective kappa agonist, U-50,488HLife Sciences, 1982